Published: Apr 09, 2021 By Alex Keown
Atara Biotherapeutics – Amie Krause was named Senior Vice President and Chief People Officer at Atara Biotherapeutics. In this role, Krause will be tasked with building a company culture that “rewards” values through actions and results. Prior to her tenure with Atara, Krause held several HR leadership positions at Amgen, including her role as Global HR Lead, Organizational Effectiveness during which she served as the human resources lead for Amgen’s global commercial operations covering the Americas, Europe, Asia, and the Middle East.
PsyBio Therapeutics – Michael Spigarelli was named chief medical officer of Ohio-based PsyBio. Before PsyBio Therapeutics, Spigarelli served as CMOr for Lumen Bioscience, a clinical-stage biopharmaceutical company developing biologic drugs for highly prevalent diseases. Prior to that, he served as Vice President of Medical Affairs for Immucor, Inc., a leading provider of transfusion and tran
Form 6-K ADC Therapeutics SA For: Apr 06
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
You Can Now Watch YouTube Kids in Arabic
albawaba.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from albawaba.com Daily Mail and Mail on Sunday newspapers.
Search jobs Overland ADCT BioPharma Appoints Eric Koo as Chief Executive Officer
Senior pharmaceutical executive with deep oncology experience in Asia formerly of Takeda, MSD, Bayer and Pfizer
BOSTON, SHANGHAI & LAUSANNE, Switzerland (BUSINESS WIRE) Overland ADCT BioPharma, a joint venture created by Overland Pharmaceuticals and ADC Therapeutics SA (NYSE: ADCT), today announced the appointment of Eric Koo, BSc, MBA, as Chief Executive Officer. Mr. Koo brings more than 25 years of pharmaceutical industry and business management experience to Overland ADCT BioPharma with a proven track record of executing successful drug approvals and launches across Asia.
“Overland ADCT BioPharma has a tremendous opportunity to bridge the clinical gap between the U.S., Europe and Asia through the expanded reach of innovative cancer medicines like antibody drug conjugates,” said Eric Koo, BSc, MBA. “It is an honor to assume the role of Chief Executive Officer and I l
What the growing trade gap means for UAE businesses
DUBAI, 23 days ago Ongoing market corrections, unexpected shocks and supply chain disruptions, and a marked liquidity crunch caused by the Covid-19 pandemic clearly mean that trade will be very different going forward. The banking sector has not been spared from these economic shocks with banks around the world facing significant challenges in terms of liquidity and profitability. Regionally, several banks have shown variability, exacerbated by high-profile defaults and supply chain instability. One of the pandemic’s most significant impacts on the economic environment is that it created a growing trade finance gap – which refers to financing for trade in the form of letters of credit (LOC), guarantees or insurance provided by an intermediary. Before Covid-19, the world’s trade finance gap stood at $1.5 trillion, according to the Asian Development Bank (ADB) and International Chamber of Commerce (ICC).